Journal · Clinical medicine · Updated 21 November 2026
Clinical and Experimental Medicine
Read Clinical and Experimental Medicine articles on DeepDyve. No university library needed.
Clinical and Experimental Medicine publishes clinical and laboratory research across medicine, with a strong focus on cancer, immunology and drug safety, from tumour biomarkers and metastasis to rare infections. Springer Nature publishes it. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
Clinical and Experimental Medicine at a glance
- Full title
- Clinical and Experimental Medicine
- Abbreviation (NLM)
- Clin Exp Med
- Publisher
- Springer Nature
- Print ISSN
- 1591-8890
- Online ISSN (eISSN)
- 1591-9528
- First published
- 2001
- Subjects
- Medicine
- Access model
- Open access since 2024
Ways to access Clinical and Experimental Medicine
All of the articles Clinical and Experimental Medicine published from January 1 to November 19, 2026 are open access and free to read. For older articles, look for the authors’ manuscript, check a library, or read them on DeepDyve.
- Open access articles. 100% of Clinical and Experimental Medicine articles published from January 1 to November 19, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
- The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
- Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to Clinical and Experimental Medicine. Check its journal list and whether it offers remote access.
- DeepDyve. Read Clinical and Experimental Medicine articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.
Impact factor and metrics
Clinical and Experimental Medicine’s 2025 Journal Impact Factor is 4.5, and its 5-year Impact Factor is 4.4.
4.5
Journal Impact Factor (2025)
4.4
5-year Impact Factor (2025)
3 days
Median time to first decision
1.4M
Downloads (2025)
Source: journal metrics on the Clinical and Experimental Medicine homepage (Springer Nature), checked November 21, 2026. Impact Factor from Clarivate Journal Citation Reports.
Recent Clinical and Experimental Medicine research worth reading
Published January to March 2026. Summaries describe what the authors report.
-
Artificial intelligence in immunotherapy: revolutionizing diagnostic and therapeutic applications in cancer and autoimmune diseases
The authors review how artificial intelligence supports immunotherapy in cancer and autoimmune disease, from biomarker discovery and predicting checkpoint inhibitor response to CAR-T optimization, noting imaging and pathology models that often report AUC values of about 0.70–0.95.
Alshorman et al. · Clinical and Experimental Medicine, published online March 6, 2026 · DOI 10.1007/s10238-026-02107-5
-
MUC1/CA15-3 identifies a clear cell renal carcinoma characterized by Sunitinib response with a specific metabolic signature
The authors report that MUC1 marks a highly angiogenic, more aggressive form of clear cell renal carcinoma, and that high serum levels of its soluble form, CA15-3, signal poor survival and predict response to sunitinib in metastatic disease.
Lucarelli et al. · Clinical and Experimental Medicine, published online January 14, 2026 · DOI 10.1007/s10238-026-02042-5
-
Metastatic organotropism in peritoneal metastasis: Paget’s hypothesis revisited
The authors review how cancer-derived exosomes help tumour cells spread to the peritoneum, preparing a pre-metastatic niche in line with Paget’s seed and soil hypothesis, and note that mesenchymal subtypes such as diffuse gastric cancer are especially prone to this route.
Kim et al. · Clinical and Experimental Medicine, published online January 29, 2026 · DOI 10.1007/s10238-025-01868-9
-
Mechanistic insights into atorvastatin-induced hepatotoxicity: molecular pathways, clinical relevance, and strategies for safer personalized therapy
The authors review how atorvastatin can injure the liver through mitochondrial dysfunction, oxidative stress, bile acid disruption and inflammation, shaped by variants in SLCO1B1, CYP3A4/5 and UGT1A1, and discuss genotype-guided dosing and liver monitoring as preventive strategies.
Abdel-Rasol et al. · Clinical and Experimental Medicine, published online March 5, 2026 · DOI 10.1007/s10238-026-02091-w
-
Deciphering whipple’s disease complexity
The authors review Whipple’s disease, a rare infection by Tropheryma whipplei with an incidence of about 1 per million, covering its varied symptoms, diagnosis and treatment, and call for more research and guidelines given the limits of current treatment options.
Korybski et al. · Clinical and Experimental Medicine, published online February 6, 2026 · DOI 10.1007/s10238-026-02064-z
See every Clinical and Experimental Medicine article on DeepDyve
Related journals
Questions about Clinical and Experimental Medicine
How can I read Clinical and Experimental Medicine articles without a subscription?
100% of Clinical and Experimental Medicine articles published from January 1 to November 19, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Clinical and Experimental Medicine articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for Clinical and Experimental Medicine?
Clinical and Experimental Medicine’s NLM (PubMed) abbreviation is Clin Exp Med.
What is the ISSN of Clinical and Experimental Medicine?
The print ISSN is 1591-8890 and the online ISSN is 1591-9528.
What is the impact factor of Clinical and Experimental Medicine?
Clinical and Experimental Medicine’s Journal Impact Factor is 4.5 (2025), and its 5-year Impact Factor is 4.4, according to Springer Nature’s published metrics.
Is Clinical and Experimental Medicine open access?
Yes. Clinical and Experimental Medicine has published open access since 2024: 359 of the 359 articles it published from January 1 to November 19, 2026 carry a Creative Commons license, per Crossref.
Clinical and Experimental Medicine articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.
Start reading Clinical and Experimental Medicine today
One month free, then less than $2 a day. Clinical and Experimental Medicine, plus millions of articles from thousands of journals.





